KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 99 filers reported holding KURA ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,623,999 | -38.0% | 1,932,456 | -28.1% | 5.58% | +31.1% |
| Q2 2023 | $28,425,476 | +764.0% | 2,686,718 | +2402.4% | 4.26% | +172.1% |
| Q3 2020 | $3,290,000 | -70.5% | 107,367 | -84.3% | 1.56% | -67.3% |
| Q2 2020 | $11,166,000 | -22.6% | 685,000 | -52.8% | 4.79% | -28.9% |
| Q1 2020 | $14,428,000 | +1.3% | 1,450,000 | +40.0% | 6.74% | +7.8% |
| Q4 2019 | $14,245,000 | +5.7% | 1,036,000 | +16.6% | 6.26% | -16.3% |
| Q3 2019 | $13,473,000 | -21.2% | 888,152 | +2.3% | 7.47% | -13.2% |
| Q2 2019 | $17,087,000 | +495.8% | 867,810 | +401.9% | 8.62% | +586.5% |
| Q1 2019 | $2,868,000 | -35.5% | 172,894 | -45.4% | 1.26% | -45.3% |
| Q4 2018 | $4,445,000 | +0.1% | 316,581 | +24.8% | 2.30% | -7.3% |
| Q3 2018 | $4,439,000 | -15.3% | 253,631 | -11.9% | 2.48% | -35.6% |
| Q2 2018 | $5,240,000 | – | 287,887 | – | 3.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
| GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
| Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
| BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
| Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
| Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
| NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
| DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
| PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |